1. Home
  2. LOVE vs TNXP Comparison

LOVE vs TNXP Comparison

Compare LOVE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOVE
  • TNXP
  • Stock Information
  • Founded
  • LOVE 1998
  • TNXP 2007
  • Country
  • LOVE United States
  • TNXP United States
  • Employees
  • LOVE N/A
  • TNXP N/A
  • Industry
  • LOVE Other Specialty Stores
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOVE Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • LOVE Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • LOVE 280.7M
  • TNXP 365.8M
  • IPO Year
  • LOVE 2018
  • TNXP N/A
  • Fundamental
  • Price
  • LOVE $18.27
  • TNXP $38.62
  • Analyst Decision
  • LOVE Strong Buy
  • TNXP Buy
  • Analyst Count
  • LOVE 5
  • TNXP 1
  • Target Price
  • LOVE $30.40
  • TNXP $70.00
  • AVG Volume (30 Days)
  • LOVE 206.8K
  • TNXP 1.3M
  • Earning Date
  • LOVE 09-11-2025
  • TNXP 08-15-2025
  • Dividend Yield
  • LOVE N/A
  • TNXP N/A
  • EPS Growth
  • LOVE N/A
  • TNXP N/A
  • EPS
  • LOVE 0.82
  • TNXP N/A
  • Revenue
  • LOVE $686,358,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • LOVE $6.64
  • TNXP $22.87
  • Revenue Next Year
  • LOVE $7.24
  • TNXP $711.66
  • P/E Ratio
  • LOVE $22.11
  • TNXP N/A
  • Revenue Growth
  • LOVE N/A
  • TNXP N/A
  • 52 Week Low
  • LOVE $12.12
  • TNXP $6.76
  • 52 Week High
  • LOVE $39.49
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • LOVE 45.25
  • TNXP 45.13
  • Support Level
  • LOVE $17.31
  • TNXP $41.64
  • Resistance Level
  • LOVE $20.53
  • TNXP $50.39
  • Average True Range (ATR)
  • LOVE 0.80
  • TNXP 4.02
  • MACD
  • LOVE 0.02
  • TNXP -0.64
  • Stochastic Oscillator
  • LOVE 29.80
  • TNXP 1.34

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: